Hyperglycemia aggravates atrial interstitial fibrosis, ionic remodeling and vulnerability to atrial fibrillation in diabetic rabbits;Hiperglisemi diyabetik tavşanlarda atriyal interstisiyel fibrosis, iyonik remodeling ve atriyal fibrilasyon duyarlılıǧını arttırmaktadır

Anadolu Kardiyoloji Dergisi

Volumn 12, Issue 7, 2012, Pages 543-550

  Liu, Changle ^a   Fu, Huaying ^a   Li, Jian ^a   Yang, Wansong ^a   Cheng, Lijun ^a   Liu, Tong ^a   Li, Guangping ^a  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Animals; Atrial fibrillation; Atrial interstitial fibrosis; Hyperglycemia; Ionic remodeling

Indexed keywords

ALLOXAN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; COMPLICATION; DISEASE MODEL; ELECTROCARDIOGRAPHY; EXPERIMENTAL DIABETES MELLITUS; FEMALE; FIBROSIS; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART ATRIUM REMODELING; HYPERGLYCEMIA; MALE; METABOLISM; PATHOPHYSIOLOGY; RABBIT; RANDOMIZATION;

ALLOXAN; ANIMALS; ATRIAL FIBRILLATION; ATRIAL REMODELING; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; FEMALE; FIBROSIS; HEART ATRIA; HYPERGLYCEMIA; MALE; RABBITS; RANDOM ALLOCATION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84868289929     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2012.188     Document Type: Article

References (36)

1. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92: 1954-168. [CrossRef]
2. Nattel S, Shiroshita-Takeshita A, Cardin S, Pelletier P. Mechanisms of atrial remodelling and clinical relevance. Curr Opin Cardiol 2005; 20: 21-25.
3. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996; 94: 2968-2974. [CrossRef]
4. de Mello WC. Angiotensin (1-7) re-establishes impulse conduction in cardiac muscle during ischaemia-reperfusion. The role of the sodium pump. J Renin Angiotensin Aldosterone Syst 2004; 5: 203-208. [CrossRef]
5. Shinagawa K, Mitamura H, Ogawa S, Nattel S. Effects of inhibiting Na+/ H+- exchange or angiotensin converting enzyme on atrial tachycardiainduced remodeling. Cardiovasc Res 2002; 54: 438-446. [CrossRef]
6. Gaspo R, Bosch RF, Bou-Abboud E, Nattel S. Tachycardia-induced changes in sodium current in a chronic dog model of atrial fibrillation. Circ Res 1997; 81: 1045-1052. [CrossRef]
7. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol 2005; 105: 315-318. [CrossRef]
8. Levy S. Atrial fibrillation, the arrhythmia of the elderly, causes and associated conditions. Anadolu Kardiyol Derg 2002; 2: 55-60.
9. Lip GY, Varughese GI. Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links. Int J Cardiol 2005; 105: 319-321. [CrossRef]
10. Huxley RR, Filion KB, Konety S, Alonso A. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol 2011; 108: 56-62. [CrossRef]
11. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007; 115: 3213-3223. [CrossRef]
12. Hayden MR, Chowdhury N, Govindarajan G, Karuparthi PR, Habibi J, Sowers JR. Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome. J Cardiometab Syndr 2006; 1: 326-333. [CrossRef]
13. Yue L, Feng J, Li GR, Nattel S. Transient outward and delayed rectifier currents in canine atrium: properties and role of isolation methods. Am J Physiol 1996; 270: H2157-H2168.
14. Li D, Melnyk P, Feng J, Wang Z, Petrecca K, Shrier A, et al. Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation 2000; 101: 2631-2638. [CrossRef]
15. Karmazínová M, Lacinová L. Measurement of cellular excitability by whole cell patch clamp technique. Physiol Res 2010; 59 Suppl 1: S1-S7.
16. Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 2008; 117: 1255-1260. [CrossRef]
17. Nichols GA, Reinier K, Chugh SS. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care 2009; 32: 1851-1856. [CrossRef]
18. Dublin S, Glazer NL, Smith NL, Psaty BM, Lumley T, Wiggins KL, et al. Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med 2010; 25: 853-858. [CrossRef]
19. Karaca M, Kinay O, Nazli C, Bic̃roǧlu S, Vatansever F, Ergene AO. The time interval from the initiation of the P-wave to the start of left atrial appendage ejection flow: does it reflect interatrial conduction time? Echocardiography 2007; 24: 810-815. [CrossRef]
20. Kato T, Yamashita T, Sekiguchi A, Sagara K, Takamura M, Takata S, et al. What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol 2006; 17: 890-894. [CrossRef]
21. Kaminski KA, Szepietowska B, Bonda T, Kozuch M, Mencel J, Malkowski A, et al. CCN2 protein is an announcing marker for cardiac remodeling following STZ- induced moderate hyperglycemia in mice. Pharmacol Rep 2009; 61: 496-503.
22. Van Wagoner DR, Pond AL, McCarthy PM, Trimmer JS, Nerbonne JM. Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 1997; 80: 772-781. [CrossRef]
23. Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Külkamp V. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res 1999; 44: 121-131. [CrossRef]
24. Van Wagoner DR, Pond AL, Lamorgese M, Rossie SS, McCarthy PM, Nerbonne JM. Atrial L-type Ca2+ currents and human atrial fibrillation. Circ Res 1999; 85: 428-436. [CrossRef]
25. Yue L, Feng J, Gaspo R, Li G, Wang Z, Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 1997; 81: 512-525. [CrossRef]
26. Saffitz JE. Douglas P. Zipes Lecture. Biology and pathobiology of cardiac connexins: from cell to bedside. Heart Rhythm 2006; 3: 102-107. [CrossRef]
27. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristies of a new model of sustained atrial fibrillation. Circulation 1995; 91: 1588-1595. [CrossRef]
28. Elvan A, Wylie K, Zipes DP. Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs: electrophysiological remodeling. Circulation 1996; 94: 2953-2960. [CrossRef]
29. Kumagai K, Akimitsu S, Kawahira K, Kawanami F, Yamanouchi Y, Hiroki T, et al. Electrophysiological properties in chronic lone atrial fibrillation. Circulation 1991; 84: 1662-1668. [CrossRef]
30. Cosio FG, Palacios J, Vidal JM, Cocina EG, Gómez-Sánchez MA, Tamargo L. Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: a possible manifestation of the background for reentry. Am J Cardiol 1983; 51: 122-130. [CrossRef]
31. Shimizu A, Fukatani M, Tanigawa M, Mori M, Hashiba K. Intraatrial conduction delay and fragmented atrial activity in patients with paroxysmal atrial fibrillation. Jpn Circ J 1989; 53: 1023-1030. [CrossRef]
32. Yue L, Melnyk P, Gaspo R, Wang Z, Nattel S. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. Circ Res 1999; 84: 776-784. [CrossRef]
33. Duff HJ, Offord J, West J, Catterall WA. Class I and IV antiarrhythmic drugs and cytosolic calcium regulate mRNA encoding the sodium channel alpha subunit in rat cardiac muscle. Mol Pharmacol 1992; 42: 570-574.
34. Kume O, Takahashi N, Wakisaka O, Nagano-Torigoe Y, Teshima Y, Nakagawa M, et al. Pioglitazone Attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats. Heart Rhythm 2011; 8: 278-285. [CrossRef]
35. Xu D, Murakoshi N, Igarashi M, Hirayama A, Ito Y, Seo Y, et al. PPAR-γ Activator pioglitazone prevents age-related atrial fibrillation susceptibility by improving antioxidant capacity and reducing apoptosis in a rat model. J Cardiovasc Electrophysiol 2012; 23:209-217. [CrossRef]
36. Doǧan A, Akçay S. The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences ofatrial fibrillation. Anadolu Kardiyol Derg 2009; 9: 505-511.